Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight ...

While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...

Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The ...

An exasperated Copperfield on the trials and tribulations that Mounjaro prescribing has wreaked on general practice ...

Eli Lilly and Company (LLY), one of the world’s leading pharmaceutical giants, might have just unveiled its next major growth catalyst — one that could significantly bolster its dominant position in ...

Medical professionals are raising concerns about patients who discontinue popular weight loss medications experiencing ...

A chip addict who ballooned to 280 pounds scoffing down four bags a day managed to lose half her body weight naturally — ...